A 10-year study of more than 1,200 patients with low-risk papillary microcarcinoma (PMC) of the thyroid led researchers to conclude that close and continuous monitoring is an acceptable first-line approach to patient management instead of immediate surgery to remove the tumor.
Standard treatment for postmenopausal breast cancer is to give a hormonal breast cancer drug for 5 years following surgical removal of the tumour.
Diabetes and high BMI (a BMI over 25 kg/m2) were the cause of 5.6% of new cancer cases worldwide in 2012 – equivalent to 792600 cases, according to the first study to quantify the proportion of cancers attributable to diabetes and high BMI published in The Lancet Diabetes & Endocrinology journal.
When cannabinoids activate signaling pathways in cancer cells they can stimulate a cell death mechanism called apoptosis, unleashing a potent anti-tumor effect. Yet cannabinoids, which have also shown strong activity against human tumor tissue grown in animal models, have undergone minimal testing in patients.
Women who received hormone stimulation for fertility preservation did not have a higher relapse rate in breast cancer compared with unexposed control women in a study from Karolinska Institutet in Sweden published in Breast Cancer Research and Treatment. The results could influence the clinical practice for young cancer patients wishing to pursue fertility preservation.
“The significance of palliative care extends far beyond ‘end-of-life treatment’ for cancer patients,” Secretary General of the World Federation of Neurology (WFN) Prof Wolfgang Grisold emphasizes at the occasion of XXIII World Congress for Neurology in Kyoto. There are a number of important areas for palliative care precisely in neurology and a steadily growing demand for it – not least due to ever higher life expectancy rates worldwide.